VION PHARMACEUTICALS, INC

Organization

NEW HAVEN, CT, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Combination therapy comprising cloretazine
- Patent number 7,605,137
- Issue date Oct 20, 2009
- Vion Pharmaceuticals, Inc.
- Ivan King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduced virulence
- Patent number 7,514,089
- Issue date Apr 7, 2009
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for tumor-targeted delivery of effector mo...
- Patent number 7,452,531
- Issue date Nov 18, 2008
- Vion Pharmaceuticals, Inc.
- David G. Bermudes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-select...
- Patent number 7,405,317
- Issue date Jul 29, 2008
- Vion Pharmaceuticals Inc.
- Xu Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduced virulence
- Patent number 7,354,592
- Issue date Apr 8, 2008
- Vion Pharmaceuticals, Inc.
- David Bermudes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Alkylguanyltransferase assays
- Patent number 7,273,714
- Issue date Sep 25, 2007
- Vion Pharmaceuticals, Inc.
- Ivan C. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for tumor-targeted delivery of effector mo...
- Patent number 6,962,696
- Issue date Nov 8, 2005
- Vion Pharmaceuticals Inc.
- David G. Bermudes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for use of genetically modified tumor-targeted bacteria wit...
- Patent number 6,923,972
- Issue date Aug 2, 2005
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral agents and methods of treating viral infections
- Patent number 6,911,460
- Issue date Jun 28, 2005
- Vion Pharmaceuticals, Inc.
- Ivan C. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduced virulence
- Patent number 6,863,894
- Issue date Mar 8, 2005
- Vion Pharmaceuticals, Inc.
- David Bermudes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Water-soluble SHPs as novel alkylating agents
- Patent number 6,855,695
- Issue date Feb 15, 2005
- Vion Pharmaceuticals, Inc.
- Xu Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduce virulence
- Patent number 6,475,482
- Issue date Nov 5, 2002
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified prodrug forms of AP/AMP
- Patent number 6,458,816
- Issue date Oct 1, 2002
- Vion Pharmaceuticals, Inc.
- Terrence W. Doyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduced virulence
- Patent number 6,447,784
- Issue date Sep 10, 2002
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified tumor-targeted bacteria with reduced virulence
- Patent number 6,080,849
- Issue date Jun 27, 2000
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for high-yield diastereoselective synthesis of dideoxynuc...
- Patent number 6,005,097
- Issue date Dec 21, 1999
- Vion Pharmaceuticals, Inc.
- Shu-Hui Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of ribonucleotide reductase inhibitors 3-...
- Patent number 5,869,676
- Issue date Feb 9, 1999
- Vion Pharmaceuticals, Inc.
- ChuanSheng Niu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
- Patent number 5,767,134
- Issue date Jun 16, 1998
- Vion Pharmaceuticals, Inc.
- Jun Li
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-select...
- Publication number 20090075945
- Publication date Mar 19, 2009
- VION PHARMACEUTICALS, INC.
- Xu Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alkylguanyltransferase Assays
- Publication number 20080299556
- Publication date Dec 4, 2008
- VION PHARMACEUTICALS, INC.
- Ivan King
- G01 - MEASURING TESTING
Information Patent Application
ALKYLGUANYLTRANSFERASE ASSAYS
- Publication number 20080076132
- Publication date Mar 27, 2008
- Vion Pharmaceuticals, Inc.
- Ivan C. King
- G01 - MEASURING TESTING
Information Patent Application
Genetically modified tumor-targeted bacteria with reduced virulence
- Publication number 20070009489
- Publication date Jan 11, 2007
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antiviral agents and methods of treating viral infections
- Publication number 20050261251
- Publication date Nov 24, 2005
- VION PHARMACEUTICALS, INC.
- Ivan C. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genetically modified tumor-targeted bacteria with reduced virulence
- Publication number 20050255088
- Publication date Nov 17, 2005
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for tumor-targeted delivery of effector mo...
- Publication number 20050249706
- Publication date Nov 10, 2005
- Vion Pharmaceuticals, Inc.
- David G. Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Water-soluble SHPs as novel alkylating agents
- Publication number 20050043244
- Publication date Feb 24, 2005
- VION PHARMACEUTICALS, INC.
- Xu Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for tumor-targeted delivery of effector mo...
- Publication number 20040229338
- Publication date Nov 18, 2004
- Vion Pharmaceuticals, Inc.
- Ivan C. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for use of genetically modified tumor-targeted bacteria wit...
- Publication number 20030170276
- Publication date Sep 11, 2003
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for delivery of an agent using attenuated...
- Publication number 20030113293
- Publication date Jun 19, 2003
- Vion Pharmaceuticals, Inc.
- David G. Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genetically modified tumor-targeted bacteria with reduced virulence
- Publication number 20030109026
- Publication date Jun 12, 2003
- Vion Pharmaceuticals, Inc.
- David Bermudes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
77237284 - INAUGRA
- Serial number 77237284
- Filing date Jul 24, 2007
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77237308 - ONBAZIS
- Serial number 77237308
- Filing date Jul 24, 2007
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77237292 - ONRIGIN
- Serial number 77237292
- Filing date Jul 24, 2007
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77237299 - CANZELIC
- Serial number 77237299
- Filing date Jul 24, 2007
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78812334 - IRAFAN
- Serial number 78812334
- Filing date Feb 10, 2006
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78812337 - IRASAN
- Serial number 78812337
- Filing date Feb 10, 2006
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78812341 - LAROSAN
- Serial number 78812341
- Filing date Feb 10, 2006
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78812344 - AMLIFAN
- Serial number 78812344
- Filing date Feb 10, 2006
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78344057 - CLORETAZINE
- Serial number 78344057
- Registration number 2974323
- Filing date Dec 22, 2003
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75304329 - TRIAPINE
- Serial number 75304329
- Registration number 2232890
- Filing date Jun 6, 1997
- Vion Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75027302 - TAPET
- Serial number 75027302
- Registration number 2192509
- Filing date Dec 5, 1995
- OncoRx, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
75025987 - VION
- Serial number 75025987
- Registration number 2074491
- Filing date Dec 1, 1995
- OncoRx, Inc.
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 13

Research Projects

Information Research Project
Determination of Triapine Antiviral Activity
- Application id 6585852
- Award notice date Sep 10, 2003
Information Research Project
Genetic Improvements of Tumor-Targeted Salmonella
- Application id 6548941
- Award notice date Sep 13, 2002
Information Research Project
POTENTIATING THE ANTI-TUMOR ACTIVITY OF SALMONELLA
- Application id 6444319
- Award notice date May 1, 2002
Information Research Project
Akylating agent Water-soluble Sulfonyl Hydrazine Prodrug
- Application id 6403098
- Award notice date Jun 26, 2001
Information Research Project
BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY
- Application id 6342093
- Award notice date Dec 18, 2000
Information Research Project
SALMONELLA WITH INDUCIBLE ANTICANCER GENES
- Application id 6074570
- Award notice date Apr 5, 2000
Information Research Project
BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY
- Application id 6075912
- Award notice date Jan 6, 2000
Information Research Project
INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
- Application id 2895745
- Award notice date Apr 7, 1999
Information Research Project
INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
- Application id 2650134
- Award notice date Apr 22, 1998
Information Research Project
REDUCED TOXICITY OF TUMOR-TARGETED SALMONELLA
- Application id 2728391
- Award notice date Feb 27, 1998
Information Research Project
INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
- Application id 2010641
- Award notice date Sep 27, 1996
Information Research Project
PRELIMINARY VALIATION OF NON-INVASIVE TUMOR IMAGING BY T
- Application id 6336174
Information Research Project
Identification of tumoricidal compounds in Salmonella
- Application id 6583589

VION PHARMACEUTICALS, INC

Organization

Patents Grantslast 30 patents

Combination therapy comprising cloretazine

Genetically modified tumor-targeted bacteria with reduced virulence

Compositions and methods for tumor-targeted delivery of effector mo...

Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-select...

Genetically modified tumor-targeted bacteria with reduced virulence

Alkylguanyltransferase assays

Compositions and methods for tumor-targeted delivery of effector mo...

Methods for use of genetically modified tumor-targeted bacteria wit...

Antiviral agents and methods of treating viral infections

Genetically modified tumor-targeted bacteria with reduced virulence

Water-soluble SHPs as novel alkylating agents

Genetically modified tumor-targeted bacteria with reduce virulence

Modified prodrug forms of AP/AMP

Genetically modified tumor-targeted bacteria with reduced virulence

Genetically modified tumor-targeted bacteria with reduced virulence

Processes for high-yield diastereoselective synthesis of dideoxynuc...

Process for the synthesis of ribonucleotide reductase inhibitors 3-...

Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP

Patents Applicationslast 30 patents

Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-select...

Alkylguanyltransferase Assays

ALKYLGUANYLTRANSFERASE ASSAYS

Genetically modified tumor-targeted bacteria with reduced virulence

Antiviral agents and methods of treating viral infections

Genetically modified tumor-targeted bacteria with reduced virulence

Compositions and methods for tumor-targeted delivery of effector mo...

Water-soluble SHPs as novel alkylating agents

Compositions and methods for tumor-targeted delivery of effector mo...

Methods for use of genetically modified tumor-targeted bacteria wit...

Compositions and methods for delivery of an agent using attenuated...

Genetically modified tumor-targeted bacteria with reduced virulence

Trademarklast 30 trademarks

77237284 - INAUGRA

77237308 - ONBAZIS

77237292 - ONRIGIN

77237299 - CANZELIC

78812334 - IRAFAN

78812337 - IRASAN

78812341 - LAROSAN

78812344 - AMLIFAN

78344057 - CLORETAZINE

75304329 - TRIAPINE

75027302 - TAPET

75025987 - VION

NIH Research Projectlast 12 months

Research Projects

Determination of Triapine Antiviral Activity

Genetic Improvements of Tumor-Targeted Salmonella

POTENTIATING THE ANTI-TUMOR ACTIVITY OF SALMONELLA

Akylating agent Water-soluble Sulfonyl Hydrazine Prodrug

BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY

SALMONELLA WITH INDUCIBLE ANTICANCER GENES

BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY

INHIBITORS OF RIBONUCLEOTIDE REDUCTASE

INHIBITORS OF RIBONUCLEOTIDE REDUCTASE

REDUCED TOXICITY OF TUMOR-TARGETED SALMONELLA

INHIBITORS OF RIBONUCLEOTIDE REDUCTASE

PRELIMINARY VALIATION OF NON-INVASIVE TUMOR IMAGING BY T

Identification of tumoricidal compounds in Salmonella